x1_c86848x8x1.jpg
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
User Publications: HPLC-ECD, Microdialysis & Optogenetics
Untitled
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
Kenta Hagihara - Engineer - Fuji America Corporation
MORI Atsunori (Research Center for Membrane and Film Technology